Physician profile
Patrick Grippo
NPI 1255449518
$1,986.02
in general payments reported to CMS, 2019-2025
20 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $90.35 · 2021: $62.50 · 2022: $63.08 · 2023: $217 · 2024: $444 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,013.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $803.27 | 2019-2025 | Renasys Go V2 Home, Pico, Renasys Touch |
| Organogenesis INC. | $271.24 | 2019-2025 | Affinity, Puraply |
| Amarin Pharma, INC. | $124.57 | 2019-2020 | |
| Shockwave Medical, INC | $109.76 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $103.68 | 2019 | |
| Mimedx Group, INC. | $102.09 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $72.79 | 2019 | |
| Sanofi-Aventis U.S. LLC | $64.41 | 2019 | |
| Janssen Pharmaceuticals, INC | $60.52 | 2019 | |
| Amgen INC. | $49.63 | 2019 | |
| Stryker Corporation | $40.99 | 2024 | Prostep Mica, 7 X 23mm Citrelock Implant |
| Reprise Biomedical, INC. | $35.31 | 2024 | Miro3d |
| Astrazeneca Pharmaceuticals Lp | $26.27 | 2019-2020 | |
| Hydrofera LLC | $23.72 | 2023 | Hydrofera Blue |
| Bioventus LLC | $22.94 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $18.38 | 2023 | Nuzyra |
| Lundbeck LLC | $16.73 | 2019 | |
| Tactile Systems Technology INC | $14.80 | 2023 | Entre Plus, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $13.71 | 2019 | |
| Pfizer INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Grippo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.